Abstract:Objective Alveolar macrophages (AMs) are critical for maintaining the homeostasis of pulmonary microenvironment. They process surfactants to ensure alveoli patency, and also serve as the first line of immune defense against pathogen invasion. Available studies have shown that monocyte-derived AMs continuously release pro-inflammatory cytokines and chemokines, recruiting other immune cells to the damaged area during pulmonary fibrosis. These monocyte-derived AMs maintains and amplifies inflammation, playing a negative role in pulmonary fibrosis progression. Current researches have predominantly focused on the gene expression levels of AMs in pulmonary fibrosis microenvironment, with less emphasis on the function and regulation of proteins. This study aims to investigate the differentially expressed proteins (DEPs) of AMs under normal physiological conditions and after pulmonary fibrosis, in order to gain a more comprehensive understanding of the role of AMs in the progression of pulmonary fibrosis. Methods Firstly, the construction of bleomycin-induced pulmonary fibrosis mouse models was evaluated through using measurements such as body mass, lung coefficient, lung wet-to-dry mass ratio, H&E staining and Masson staining. Subsequently, AMs from both the saline controls and the pulmonary fibrosis models (2.5x10(5) cells per sample) were collected using FACS sorting, and protein expression profiles of these cells were obtained through label-free proteomics approach. The quality of the proteomic data was assessed by comparing our saline control proteomic data with public proteomic data of physiological AMs. Thirdly, DEPs analysis between the saline controls and the bleomycin groups was carried out using R package Prostar. Functional enrichment analyses of significantly upregulated DEPs were performed using R package Clusterprofiler for GO and KEGG pathways. Finally, the STRING database was used to explore the protein-protein interaction networks related to phagocytosis regulation, inflammatory response regulation, and I-xB/NF-xB signaling pathway. The expression levels of Tlr2 and Pycard were detected respectively by FACS and western blotting. Results Compared to the saline controls, mice in the bleomycin groups exhibited a lower average body mass, extensive infiltration of inflammatory cells, and deposition of collagen in the lungs. This indicates that bleomycin successfully induced pulmonary fibrosis in mouse models. The proteomic data of AMs obtained from these models was of high quality and fulfilled the research requirements. A comprehensive analysis showed that 778 proteins were upregulated in pulmonary fibrosis groups compared with control groups. Moreover, the signal pathways enriched in up-regulated DEPs were related to the I-xB/NF-xB pathway, inflammatory response regulation, phagocytosis regulation, TGF-beta signaling, and HIF-1 pathway, indicating that AMs in pulmonary fibrosis microenvironment exerted pro-inflammatory and pro-fibrotic functions. Protein- protein interaction network analysis of the DEPs suggested that the interactions between Tlr2 and Pycard were control nodes for the pro-inflammatory phenotype of AMs, thereby contributing to pulmonary fibrosis progression. Further validation by FACS and Western blotting respectively confirmed that the expression levels of Tlr2 and Pycard in AMs were significantly increased after pulmonary fibrosis. Conclusion This study investigates the changes in the protein expression profile of AMs in the pulmonary fibrosis microenvironment. The results show that AMs notably enhanced the activity of various pathways associated with inflammation and fibrosis, suggesting that the interaction between Tlr2 and Pycard serves as a key control node for the highly pro- inflammatory behavior of AMs.

[Alveolar macrophage and airway inflammation in patients with chronic obstructive pulmonary disease].

[The Study of Inflammatory Mediators and Pulmonary Ventilatory Capacity in Patients with Chronic Obstructive Pulmonary Disease].

[Activation of Transcription Factors and Induction of Cytokines from Macrophages in Chronic Obstructive Pulmonary Disease].

The Roll of Alveolar Macrophages in Airway Inflammation of COPD Rats

Progress in Alveolar Macrophages

The Relationship of Macrophage Function with Receptor Expression in Patients with Chronic Obstructive Pulmonary Disease

[Alveolar macrophages in rats with chronic obstructive pulmonary disease (COPD) promotes proliferation, mucin and inflammatory factors secretion of airway epithelial cells and its mechanism]

Activity of Matrix Metalloproteinase in Airway Epithelial Cells of COPD Patients.

Alveolar macrophage proteinase/antiproteinase expression in lung function and emphysema

Relationship of alveolar macrophage plasminogen activator and elastase activities to lung function and CT evidence of emphysema

Effects of Atmospheric Fine Particulate Matter and Its Carrier Microbes on Pulmonary Microecology in Patients with COPD.

[A Study of Airway Reactivity and Nature of Chronic Asthmatic Bronchitis].

Recruited Alveolar Macrophages, in Response to Airway Epithelial-Derived Monocyte Chemoattractant Protein 1/ccl2, Regulate Airway Inflammation and Remodeling in Allergic Asthma.

Proteomic Analysis of Alveolar Macrophages in Pulmonary Fibrosis Microenvironment

Abundance of Non-Polarized Lung Macrophages with Poor Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD)

Effects of Histone Modification on Chemokines Expression in Alveolar Epithelial TypeⅡ Cells in a Rat Model of COPD

Macrophage inflammation and association with structural remodeling in pre-COPD

[Advances in Research on the Role of Alveolar Macrophage Burial Function in Chronic Obstructive Pulmonary Disease].

Macrophages with reduced expressions of classical M1 and M2 surface markers in human bronchoalveolar lavage fluid exhibit pro-inflammatory gene signatures

Resident Alveolar Macrophages Suppress, whereas Recruited Monocytes Promote, Allergic Lung Inflammation in Murine Models of Asthma

Comparative Study of Cytokine Levels in Different Respiratory Samples in Mild-to-Moderate AECOPD Patients